SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-20-000010
Filing Date
2020-02-28
Accepted
2020-02-28 10:59:46
Documents
20
Period of Report
2020-02-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 26250
2 EXHIBIT 99.1 io360.htm EX-99.1 35175
3 io360001.jpg GRAPHIC 64163
4 io360002.jpg GRAPHIC 128748
5 io360003.jpg GRAPHIC 96453
6 io360004.jpg GRAPHIC 95175
7 io360005.jpg GRAPHIC 89675
8 io360006.jpg GRAPHIC 108864
9 io360007.jpg GRAPHIC 78434
10 io360008.jpg GRAPHIC 82644
11 io360009.jpg GRAPHIC 77369
12 io360010.jpg GRAPHIC 88057
13 io360011.jpg GRAPHIC 69573
14 io360012.jpg GRAPHIC 80020
15 io360013.jpg GRAPHIC 95271
16 io360014.jpg GRAPHIC 115844
17 io360015.jpg GRAPHIC 100758
18 io360016.jpg GRAPHIC 87348
19 io360017.jpg GRAPHIC 96610
20 io360018.jpg GRAPHIC 94040
  Complete submission text file 0001583648-20-000010.txt   2334328
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 20666694
SIC: 8731 Services-Commercial Physical & Biological Research